Your browser doesn't support javascript.
COVID-19 in a human T-cell lymphotropic virus type-1 carrier.
Enomoto, Takatoshi; Shiroyama, Takayuki; Hirata, Haruhiko; Amiya, Saori; Adachi, Yuichi; Niitsu, Takayuki; Noda, Yoshimi; Hara, Reina; Fukushima, Kiyoharu; Suga, Yasuhiko; Miyake, Kotaro; Koyama, Shohei; Iwahori, Kota; Nagatomo, Izumi; Tokuhira, Natsuko; Uchiyama, Akinori; Takeda, Yoshito; Kumanogoh, Atsushi.
  • Enomoto T; Department of Respiratory Medicine and Clinical Immunology Osaka University Graduate School of Medicine Osaka Japan.
  • Shiroyama T; Department of Respiratory Medicine and Clinical Immunology Osaka University Graduate School of Medicine Osaka Japan.
  • Hirata H; Department of Respiratory Medicine and Clinical Immunology Osaka University Graduate School of Medicine Osaka Japan.
  • Amiya S; Department of Respiratory Medicine and Clinical Immunology Osaka University Graduate School of Medicine Osaka Japan.
  • Adachi Y; Department of Respiratory Medicine and Clinical Immunology Osaka University Graduate School of Medicine Osaka Japan.
  • Niitsu T; Department of Respiratory Medicine and Clinical Immunology Osaka University Graduate School of Medicine Osaka Japan.
  • Noda Y; Department of Respiratory Medicine and Clinical Immunology Osaka University Graduate School of Medicine Osaka Japan.
  • Hara R; Department of Respiratory Medicine and Clinical Immunology Osaka University Graduate School of Medicine Osaka Japan.
  • Fukushima K; Department of Respiratory Medicine and Clinical Immunology Osaka University Graduate School of Medicine Osaka Japan.
  • Suga Y; Department of Respiratory Medicine and Clinical Immunology Osaka University Graduate School of Medicine Osaka Japan.
  • Miyake K; Department of Respiratory Medicine and Clinical Immunology Osaka University Graduate School of Medicine Osaka Japan.
  • Koyama S; Department of Respiratory Medicine and Clinical Immunology Osaka University Graduate School of Medicine Osaka Japan.
  • Iwahori K; Department of Respiratory Medicine and Clinical Immunology Osaka University Graduate School of Medicine Osaka Japan.
  • Nagatomo I; Department of Respiratory Medicine and Clinical Immunology Osaka University Graduate School of Medicine Osaka Japan.
  • Tokuhira N; Department of Anesthesiology and Intensive Care Medicine Osaka University Graduate School of Medicine Osaka Japan.
  • Uchiyama A; Department of Anesthesiology and Intensive Care Medicine Osaka University Graduate School of Medicine Osaka Japan.
  • Takeda Y; Department of Respiratory Medicine and Clinical Immunology Osaka University Graduate School of Medicine Osaka Japan.
  • Kumanogoh A; Department of Respiratory Medicine and Clinical Immunology Osaka University Graduate School of Medicine Osaka Japan.
Clin Case Rep ; 10(2): e05463, 2022 Feb.
Article in English | MEDLINE | ID: covidwho-1680285
ABSTRACT
This is the first report of COVID-19 in a human T-cell lymphotropic virus type-1 (HTLV-1) carrier. HTLV-1 infection can cause immune dysfunction even in asymptomatic carriers. This case highlights the need for guidance on management of COVID-19-HTLV-1 coinfection, specifically on the appropriate use of corticosteroid treatment while considering secondary infection.
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report Language: English Journal: Clin Case Rep Year: 2022 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report Language: English Journal: Clin Case Rep Year: 2022 Document Type: Article